Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07437391
NA

Effect of L-Carnitine Supplementation in Preterm Neonates

Sponsor: Muhammad Aamir Latif

View on ClinicalTrials.gov

Summary

The current study is planned to see the effect of L-carnitine supplementation in preterm neonates suffering from RDS among the local population, as there is no such evidence available for the local population and there are conflicting statistics regarding the discharge rate of these neonates.

Official title: Effect of L-Carnitine Supplementation in Preterm Neonates Suffering From Respiratory Distress Syndrome (RDS)

Key Details

Gender

All

Age Range

1 Hour - 24 Hours

Study Type

INTERVENTIONAL

Enrollment

160

Start Date

2026-01-01

Completion Date

2026-06-30

Last Updated

2026-02-27

Healthy Volunteers

No

Interventions

DRUG

L-carnitine

Patients will receive L-carnitine at a therapeutic dosage of 30 mg/kg/day, in conjunction with a standard care regimen comprising a total dosage of 100 mg phospholipids/kg birth weight (4 ml/kg), divided into four quarter-dose aliquots.

DRUG

Standard care

Patients will get a standard care regimen comprising a total dosage of 100 mg phospholipids/kg birth weight (4 ml/kg), divided into four quarter-dose aliquots.

Locations (1)

Recep Tayyip Erdogan Hospital/Indus Hospital & Health Network

Muzaffargarh, Punjab Province, Pakistan